The American Association of Pharmaceutical Scientists (AAPS) announced the election of Dale Eric Wurster, PhD, FAAPS as president-elect of its board of directors.
On August 8, 2017, the American Association of Pharmaceutical Scientists (AAPS) announced the election of Dale Eric Wurster, PhD, FAAPS as president-elect of the association’s board of directors. Starting in November 2017 at the AAPS Annual Meeting and Exposition in San Diego, CA, he will begin a three-year term as president-elect, president and immediate past president. The meeting anticipates an attendance of over 6,500 international pharmaceutical scientists.
“I am heavily invested in the long-term success of AAPS, and I would like very much to be part of the strategizing being undertaken by the leadership team as it attempts to create an even more active and vibrant scientific organization; an organization which will be relevant to academically-diverse individuals well into the 21st century,” said Dr. Wurster in his election bulletin.
In addition to the new president-elect, Reina Bendayan, PharmD, FAAPS from University of Toronto, and Allen C. Templeton, PhD, FAAPS from Merck & Co. were elected as AAPS Members-at-Large.
Source: AAPS
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.